跳至主要内容
临床试验/NCT01482585
NCT01482585Unknown不适用

Prospective Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy

Samsung Medical Center1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2011年10月最近更新:
适应症

试验速览

阶段
不适用
入组人数
200
试验地点
1
主要终点
Prediction of tumor aggressiveness

研究概览

简要总结

to determine the values of imaging and genetic biomarkers for prediction of tumor aggressiveness and prognosis in patient with early stage lung adenocarcinoma to Identify unique copy number alteration in patient with early stage lung adenocarcinoma to evaluate the long-term change of ground-glass nodule combined with lung adenocarcinoma to suggest a guideline for planning an appropriate follow-up examination and management

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • A. Clinically and radiologically suspected lung adenocarcinoma
  • B. Newly-diagnosed Stage I or II from the clinical work up including PET/CT
  • C. Performance status of 0 to 1 on the ECOG scale
  • D. Age 20 years or older
  • E. Able to tolerable DECT imaging required by protocol
  • F. Able to give study-specific informed consent

排除标准

  • A. Prior malignancy
  • B. planning of Definitive RTx 나 neoadjuvant CCRTx
  • C. Poor cardiopulmonary reserve

结局指标

主要结局

Prediction of tumor aggressiveness

时间窗: five years

次要结局

  • prognosis of early stage lung adenocarcinoma following operation(five years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验